News

Hendrik Scholl erhält den A. Vogt-Preis zur Förderung der Augenheilkunde 2019; Josephine Jüttner den SWISS OphthAWARD 2019 für die beste experimentelle Arbeit. Wir gratulieren!

An EVI-Consensus in Ophthalmic Research defines unmet needs that can realistically be addressed in the next 5 years.

President János Áder decorated our Molecular Director with the Hungarian Saint Stephen Order, "to celebrate Hungarians whose outstanding talent and achievements serve the well-being and prosperity of many others."

A validated, fully automated and cloud-based analysis for pigmented choroidal tumors - free of charge and open access - will be further developed to detect other retinal pathologies, such as age-related macular degeneration or presence of macular fluid.

The joint eight year effort of our molecular and clinical researchers to build and test 230 AAVs with unique synthetic promoter sequences for use in the retina, and the resulting AAV library for retinal cell expression in mouse, macaque, and man is featured as research highlight in Nature Neuroscience.

IOB group leader Gray Camp is part of an international team of investigators that will receive funding from the Chan Zuckerberg Initiative (CZI) to establish a seed network for a project supporting the Human Cell Atlas (HCA), an international effort for better understanding health and disease.

The choriocapillaris is an easy and valid marker for identification of the outer retinal margin.

So what?

Find out why this greatly matters in translational ophthalmology.

In Stargardt disease, autofluorescence imaging may serve as a tool to estimate yearly rate of disease progression, using the growth of atrophic lesions, and thus as an efficacy marker for therapeutic interventions that aim to slow down the disease progression.

A review from the European Vision Institute Special Interest Focus Group is now available in Ophthalmic Research

A collection of AAVs containing synthetic promoters allow transgene expression in a broad range of retinal cell types in mice, NHPs and humans. The collaborative study of IOB molecular and clinical researchers is published in Nature Neuroscience.

Bence György, Head of our Translational Group, is first author of a study now published in Nature Medicine, describing a more precise CRISPR-Cas9 gene-editing system

In Genetics in Medicine Carlo Rivolta and coworkers describe the traces of a rare disease, which they suggest to be called Liberfarb syndrome

We hope that our first Annual Report finds your interest. Download it here...

Nature Communications today published the findings of Carlo Rivolta, our Group Leader for Ophthalmic Genetics, and his collaborators.

She has been elected Professor of Genetic Epidemiology of Ophthalmic Diseases at the Medical Faculty of the University of Basel, in a joint professorship with the University of Rotterdam. Caroline joins our Clinical Research Center.

«40 Jahre gemeinsam unterwegs» – Öffentliche Jubiläums-Infoveranstaltung im Kollegienhaus der Universität Basel am Samstag, den 15. Juni.

Hier geht es zum Programm der Tagung und zum abendlichen Dokumentarfilm